Data Management STREAM
-
Quality Insights For Ophthalmology Innovation
5/28/2025
Verana Health provides data essential to answering your questions during the drug development process, particularly in the field of ophthalmology.
-
Advanced AI-Powered TMF Automation
9/24/2021
Automate time-consuming manual processes with the industry’s only AI-assisted filing and indexing, increasing speed and quality.
-
Improving Supply Chain: Accountability, Sustainability, Optimization
Watch as industry experts explore the advancements in drug accountability facilitated through IRT, encompassing innovative methods for managing site variations and sustainable supply chains.
-
Leveraging DHTs To Improve Data Collection And Analysis
2/25/2025
How can wearable DHTs be leveraged to measure physical activity in patients with immunological diseases, enhancing clinical trials and advancing drug development?
-
Unifying Clinical Data Capture And Management
1/13/2022
This video series explores the opportunities and challenges presented by new data capture sources, looks at how clinical data management technologies and processes are transforming, and how data managers can prepare for the future of clinical data management.
-
Clinical Trial Disclosure, Transparency & Data Sharing – A Lifeline For Medicine
11/5/2020
When Craig Lipset talks pharma, people listen. The former Head of Clinical Innovation and Venture Partner at Pfizer shares his insights on clinical trial transparency and is joined by Chris Boone of AbbVie in a fireside chat.
-
Case Study: Optimizing Clinical Supply Chain With Advanced Technology
4/24/2024
In this interactive discussion, IQVIA Technologies' IRT experts delve into real-world examples and practical AI applications.
-
Utilizing Curated Data To Boost Your Urology Research And Innovation
5/28/2025
Obtain robust data from a reputable source to boost your urology research and propel your life science company's innovation in the urology space.
-
Using Data To Accelerate Racial Diversity In US Clinical Trials
11/2/2022
Historically, US clinical trials have been shown to recruit disproportionately large percentages of White patients, raising concerns about the generalizability of clinical trial results to underrepresented racial minority patient populations. Because of this, the FDA has recently reiterated its guidance stating that clinical trials need to reflect the demographic distribution of the US.
-
Why Veeva CDB
6/24/2024
Watch a two-minute video to learn how Veeva Clinical Database (CDB) aggregates, cleans, and transforms clinical data from various sources, including third-party EDCs.